
Isis A. D. Ghali
Examiner (ID: 231)
| Most Active Art Unit | 1611 |
| Art Unit(s) | 1611, 1615 |
| Total Applications | 1721 |
| Issued Applications | 501 |
| Pending Applications | 322 |
| Abandoned Applications | 932 |
Applications
| Application number | Title of the application | Filing Date | Status |
|---|---|---|---|
Array
(
[id] => 18752450
[patent_doc_number] => 20230355699
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-11-09
[patent_title] => HYPERICUM EXTRACT IN NEEM OIL FOR THE TREATMENT OF EPIDERMOLYSIS BULLOSA
[patent_app_type] => utility
[patent_app_number] => 18/246212
[patent_app_country] => US
[patent_app_date] => 2021-09-20
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 1790
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -3
[patent_words_short_claim] => 17
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18246212
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/246212 | HYPERICUM EXTRACT IN NEEM OIL FOR THE TREATMENT OF EPIDERMOLYSIS BULLOSA | Sep 19, 2021 | Pending |
Array
(
[id] => 17334440
[patent_doc_number] => 20220000771
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-01-06
[patent_title] => CHEWABLE GEL PRODUCTS FOR ACTIVE PHARMACEUTICAL INGREDIENTS
[patent_app_type] => utility
[patent_app_number] => 17/479614
[patent_app_country] => US
[patent_app_date] => 2021-09-20
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 37935
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -96
[patent_words_short_claim] => 12
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17479614
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/479614 | CHEWABLE GEL PRODUCTS FOR ACTIVE PHARMACEUTICAL INGREDIENTS | Sep 19, 2021 | Pending |
Array
(
[id] => 17312707
[patent_doc_number] => 20210401755
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-12-30
[patent_title] => SOLID FORMULATION
[patent_app_type] => utility
[patent_app_number] => 17/471330
[patent_app_country] => US
[patent_app_date] => 2021-09-10
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 6857
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -25
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17471330
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/471330 | Solid formulation | Sep 9, 2021 | Issued |
Array
(
[id] => 17312893
[patent_doc_number] => 20210401941
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-12-30
[patent_title] => MULTILAYER DRUG DELIVERY COATING FOR CONTACT LENS
[patent_app_type] => utility
[patent_app_number] => 17/469032
[patent_app_country] => US
[patent_app_date] => 2021-09-08
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 14444
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -18
[patent_words_short_claim] => 50
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17469032
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/469032 | MULTILAYER DRUG DELIVERY COATING FOR CONTACT LENS | Sep 7, 2021 | Pending |
Array
(
[id] => 18724319
[patent_doc_number] => 20230338455
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-10-26
[patent_title] => PHARMACEUTICAL COMPOSITION IN THE FORM OF A HYDROGEL COMPRISING ORANGE-DERIVED EXTRACELLULAR VESICLES
[patent_app_type] => utility
[patent_app_number] => 18/044604
[patent_app_country] => US
[patent_app_date] => 2021-09-08
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 9236
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -13
[patent_words_short_claim] => 139
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18044604
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/044604 | PHARMACEUTICAL COMPOSITION IN THE FORM OF A HYDROGEL COMPRISING ORANGE-DERIVED EXTRACELLULAR VESICLES | Sep 7, 2021 | Pending |
Array
(
[id] => 17312709
[patent_doc_number] => 20210401757
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-12-30
[patent_title] => SUBLINGUAL DELIVERY FOR MITIGATION OF SIDE EFFECTS ASSOCIATED WITH OLANZAPINE AND METFORMIN
[patent_app_type] => utility
[patent_app_number] => 17/464587
[patent_app_country] => US
[patent_app_date] => 2021-09-01
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 7676
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -17
[patent_words_short_claim] => 38
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17464587
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/464587 | SUBLINGUAL DELIVERY FOR MITIGATION OF SIDE EFFECTS ASSOCIATED WITH OLANZAPINE AND METFORMIN | Aug 31, 2021 | Abandoned |
Array
(
[id] => 17312710
[patent_doc_number] => 20210401758
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-12-30
[patent_title] => SUBLINGUAL DELIVERY FOR MITIGATION OF SIDE EFFECTS ASSOCIATED WITH TRAZODONE
[patent_app_type] => utility
[patent_app_number] => 17/464616
[patent_app_country] => US
[patent_app_date] => 2021-09-01
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 7701
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -17
[patent_words_short_claim] => 33
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17464616
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/464616 | SUBLINGUAL DELIVERY FOR MITIGATION OF SIDE EFFECTS ASSOCIATED WITH TRAZODONE | Aug 31, 2021 | Abandoned |
Array
(
[id] => 20401207
[patent_doc_number] => 12491166
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2025-12-09
[patent_title] => Method of delivering an active compound and delivery device for use in the same
[patent_app_type] => utility
[patent_app_number] => 17/460820
[patent_app_country] => US
[patent_app_date] => 2021-08-30
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 9
[patent_figures_cnt] => 24
[patent_no_of_words] => 9860
[patent_no_of_claims] => 8
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 187
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17460820
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/460820 | Method of delivering an active compound and delivery device for use in the same | Aug 29, 2021 | Issued |
Array
(
[id] => 20401207
[patent_doc_number] => 12491166
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2025-12-09
[patent_title] => Method of delivering an active compound and delivery device for use in the same
[patent_app_type] => utility
[patent_app_number] => 17/460820
[patent_app_country] => US
[patent_app_date] => 2021-08-30
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 9
[patent_figures_cnt] => 24
[patent_no_of_words] => 9860
[patent_no_of_claims] => 8
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 187
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17460820
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/460820 | Method of delivering an active compound and delivery device for use in the same | Aug 29, 2021 | Issued |
Array
(
[id] => 18829639
[patent_doc_number] => 20230398163
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-12-14
[patent_title] => FRUIT EXTRACTS FOR USE IN THE TREATMENT OF NEURODEGENERATIVE DISEASES
[patent_app_type] => utility
[patent_app_number] => 18/022877
[patent_app_country] => US
[patent_app_date] => 2021-08-24
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 16463
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -67
[patent_words_short_claim] => 32
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18022877
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/022877 | FRUIT EXTRACTS FOR USE IN THE TREATMENT OF NEURODEGENERATIVE DISEASES | Aug 23, 2021 | Pending |
Array
(
[id] => 17426993
[patent_doc_number] => 20220054701
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-02-24
[patent_title] => LIQUID MEDICAL MATERIAL
[patent_app_type] => utility
[patent_app_number] => 17/407982
[patent_app_country] => US
[patent_app_date] => 2021-08-20
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 4842
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -6
[patent_words_short_claim] => 73
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17407982
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/407982 | Liquid hemostatic medical material | Aug 19, 2021 | Issued |
Array
(
[id] => 19096530
[patent_doc_number] => 20240115757
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2024-04-11
[patent_title] => METHOD FOR MANUFACTURING MEDICAL MATERIAL OF WHICH HEMOSTASIS AND DEGRADATION RATES ARE CONTROLLABLE, AND MEDICAL MATERIAL MANUFACTURED THEREBY
[patent_app_type] => utility
[patent_app_number] => 18/043305
[patent_app_country] => US
[patent_app_date] => 2021-08-20
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 4631
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -7
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18043305
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/043305 | METHOD FOR MANUFACTURING MEDICAL MATERIAL OF WHICH HEMOSTASIS AND DEGRADATION RATES ARE CONTROLLABLE, AND MEDICAL MATERIAL MANUFACTURED THEREBY | Aug 19, 2021 | Pending |
Array
(
[id] => 19096530
[patent_doc_number] => 20240115757
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2024-04-11
[patent_title] => METHOD FOR MANUFACTURING MEDICAL MATERIAL OF WHICH HEMOSTASIS AND DEGRADATION RATES ARE CONTROLLABLE, AND MEDICAL MATERIAL MANUFACTURED THEREBY
[patent_app_type] => utility
[patent_app_number] => 18/043305
[patent_app_country] => US
[patent_app_date] => 2021-08-20
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 4631
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -7
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18043305
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/043305 | METHOD FOR MANUFACTURING MEDICAL MATERIAL OF WHICH HEMOSTASIS AND DEGRADATION RATES ARE CONTROLLABLE, AND MEDICAL MATERIAL MANUFACTURED THEREBY | Aug 19, 2021 | Pending |
Array
(
[id] => 17412621
[patent_doc_number] => 20220047525
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-02-17
[patent_title] => TRANSDERMAL PHARMACEUTICAL FORMULATIONS OF NABILONE ALONE AND IN COMBINATION WITH CANNABINOIDS
[patent_app_type] => utility
[patent_app_number] => 17/401598
[patent_app_country] => US
[patent_app_date] => 2021-08-13
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 25499
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -68
[patent_words_short_claim] => 70
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17401598
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/401598 | TRANSDERMAL PHARMACEUTICAL FORMULATIONS OF NABILONE ALONE AND IN COMBINATION WITH CANNABINOIDS | Aug 12, 2021 | Pending |
Array
(
[id] => 17412621
[patent_doc_number] => 20220047525
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-02-17
[patent_title] => TRANSDERMAL PHARMACEUTICAL FORMULATIONS OF NABILONE ALONE AND IN COMBINATION WITH CANNABINOIDS
[patent_app_type] => utility
[patent_app_number] => 17/401598
[patent_app_country] => US
[patent_app_date] => 2021-08-13
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 25499
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -68
[patent_words_short_claim] => 70
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17401598
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/401598 | TRANSDERMAL PHARMACEUTICAL FORMULATIONS OF NABILONE ALONE AND IN COMBINATION WITH CANNABINOIDS | Aug 12, 2021 | Pending |
Array
(
[id] => 17412621
[patent_doc_number] => 20220047525
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-02-17
[patent_title] => TRANSDERMAL PHARMACEUTICAL FORMULATIONS OF NABILONE ALONE AND IN COMBINATION WITH CANNABINOIDS
[patent_app_type] => utility
[patent_app_number] => 17/401598
[patent_app_country] => US
[patent_app_date] => 2021-08-13
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 25499
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -68
[patent_words_short_claim] => 70
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17401598
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/401598 | TRANSDERMAL PHARMACEUTICAL FORMULATIONS OF NABILONE ALONE AND IN COMBINATION WITH CANNABINOIDS | Aug 12, 2021 | Pending |
Array
(
[id] => 18565716
[patent_doc_number] => 20230256043
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-08-17
[patent_title] => FORMULATION PRODUCT
[patent_app_type] => utility
[patent_app_number] => 18/015952
[patent_app_country] => US
[patent_app_date] => 2021-07-13
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 4134
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -9
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18015952
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/015952 | FORMULATION PRODUCT | Jul 12, 2021 | Pending |
Array
(
[id] => 18565716
[patent_doc_number] => 20230256043
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-08-17
[patent_title] => FORMULATION PRODUCT
[patent_app_type] => utility
[patent_app_number] => 18/015952
[patent_app_country] => US
[patent_app_date] => 2021-07-13
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 4134
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -9
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18015952
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/015952 | FORMULATION PRODUCT | Jul 12, 2021 | Pending |
Array
(
[id] => 17334557
[patent_doc_number] => 20220000888
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-01-06
[patent_title] => OPHTHALMIC COMPOSITIONS
[patent_app_type] => utility
[patent_app_number] => 17/359120
[patent_app_country] => US
[patent_app_date] => 2021-06-25
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 16330
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -35
[patent_words_short_claim] => 82
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17359120
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/359120 | OPHTHALMIC COMPOSITIONS | Jun 24, 2021 | Abandoned |
Array
(
[id] => 17290842
[patent_doc_number] => 20210386681
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-12-16
[patent_title] => AMMONIA PAD WITH RELEASABLE SEAL
[patent_app_type] => utility
[patent_app_number] => 17/347256
[patent_app_country] => US
[patent_app_date] => 2021-06-14
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 1640
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -7
[patent_words_short_claim] => 88
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17347256
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/347256 | Ammonia pad with releasable seal | Jun 13, 2021 | Issued |